Charles Schwab Investment Management Inc Chroma Dex Corp. Transaction History

Charles Schwab Investment Management Inc

$557 Billion
Q2 2025

A detailed history of Charles Schwab Investment Management Inc transactions in Chroma Dex Corp. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 156,122 shares of CDXC stock, worth $958,589. This represents 0.0% of its overall portfolio holdings.

Number of Shares

156,122

Previous 144,623 7.95%

Holding current value

$958,589

Previous $997,000 3.91%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$5.42 - $7.08 $62,324 - $81,412	11,499 Added 7.95%	156,122 $958,000
Q1 2025 Sep 15, 2025	SELL	$5.26 - $8.55 $60,484 - $98,316	-11,499 Reduced 7.37%	144,623 $997,000
Q1 2025 May 09, 2025	BUY	$5.26 - $8.55 $10 - $17	2 Added 0.0%	144,623 $997,000
Q4 2024 Feb 06, 2025	BUY	$3.25 - $7.72 $14,469 - $34,369	4,452 Added 3.18%	144,621 $767,000
Q2 2024 Aug 12, 2024	BUY	$2.44 - $4.32 $281,824 - $498,968	115,502 Added 468.25%	140,169 $382,000
Q2 2022 Aug 15, 2022	SELL	$1.59 - $2.7 $163,720 - $278,016	-102,969 Reduced 80.67%	24,667 $42,000
Q4 2021 Feb 11, 2022	BUY	$3.74 - $6.7 $18,041 - $32,320	4,824 Added 3.93%	127,636 $478,000
Q3 2021 Nov 16, 2021	BUY	$6.05 - $10.41 $32,440 - $55,818	5,362 Added 4.57%	122,812 $771,000
Q2 2021 Aug 16, 2021	BUY	$6.66 - $10.92 $73,166 - $119,967	10,986 Added 10.32%	117,450 $1.16 Million
Q1 2021 May 17, 2021	BUY	$4.59 - $18.74 $24,744 - $101,027	5,391 Added 5.33%	106,464 $995,000
Q4 2020 Feb 16, 2021	BUY	$3.93 - $5.5 $19,276 - $26,977	4,905 Added 5.1%	101,073 $486,000
Q3 2020 Nov 13, 2020	SELL	$4.01 - $5.56 $17,796 - $24,675	-4,438 Reduced 4.41%	96,168 $386,000
Q2 2020 Aug 14, 2020	BUY	$3.0 - $5.52 $8,019 - $14,754	2,673 Added 2.73%	100,606 $462,000
Q1 2020 May 15, 2020	SELL	$2.54 - $4.75 $11,450 - $21,413	-4,508 Reduced 4.4%	97,933 $320,000
Q4 2019 Feb 07, 2020	BUY	$2.83 - $4.61 $14,650 - $23,865	5,177 Added 5.32%	102,441 $442,000
Q3 2019 Nov 08, 2019	BUY	$3.83 - $4.72 $22,574 - $27,819	5,894 Added 6.45%	97,264 $383,000
Q2 2019 Aug 09, 2019	BUY	$3.71 - $4.83 $25,524 - $33,230	6,880 Added 8.14%	91,370 $425,000
Q1 2019 May 14, 2019	BUY	$3.2 - $4.19 $40,608 - $53,171	12,690 Added 17.67%	84,490 $355,000
Q2 2018 Aug 08, 2018	BUY	$3.22 - $4.43 $231,196 - $318,074	71,800 New	71,800 $267,000

Others Institutions Holding CDXC

# of Institutions

171

Shares Held

28.3M

Call Options Held

143K

Put Options Held

189K

View Full List

About ChromaDex Corp.

Ticker CDXC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,350,896
Market Cap $420M
Description
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...

More about CDXC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Chroma Dex Corp. Transaction History